CIK: 0001594912
Total reported value
$29.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 92.37% | — | -22.19% | |
| 2 | NVAX | Novavax INC | Stock-Healthcare | 3.85% | — | — | |
| 3 | EPZMEUR | Epizyme INC | Stock-Other | 2.24% | — | — | |
| 4 | XLRN | Acceleron Pharma INC | Stock-Other | 1.55% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | — | EXIT | Sold out |
| 2 | NVAX | Novavax INC | — | EXIT | Sold out |
| 3 | EPZMEUR | Epizyme INC | — | EXIT | Sold out |
| 4 | XLRN | Acceleron Pharma INC | — | EXIT | Sold out |